Failure of Vancomycin Continuous Infusion against Experimental Endocarditis Due to Vancomycin-Intermediate Staphylococcus aureus

Continuous infusion of vancomycin was evaluated against experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA. Animals were infected with hVISA PC1 (vancomycin MIC, 2 mg/liter) or VISA PC3 (vancomycin MIC, 8 mg/liter) and treated for 5 days wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Entenza, J. M., Veloso, T. R., Vouillamoz, J., Giddey, M., Moreillon, P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2011
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3019629/
https://ncbi.nlm.nih.gov/pubmed/20956604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00811-10
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados